CLINICAL SIGNIFICANCE OF NESTIN AND ITS ASSOCIATION WITH SURVIVAL IN NEUROENDOCRINE LUNG TUMOURS

被引：0
|
作者：
Brominska, Barbara [1 ]
Gabryel, Piotr [2 ]
Jarmolowska-Jurczyszyn, Donata [3 ]
Janicka-Jedynska, Malgorzata [3 ]
Trojanowski, Maciej [4 ]
Sawicka-Gutaj, Nadia [1 ]
Czepczynski, Rafal [1 ]
Gut, Pawel [1 ]
Brominski, Gabriel [1 ]
Dyszkiewicz, Wojciech [2 ]
Wozniak, Aldona [3 ]
Ruchala, Marek [1 ]
机构：
[1] Poznan Univ Med Sci, Dept Endocrinol Metab & Internal Med, Przybyszewskiego 49, PL-60355 Poznan, Poland
[2] Poznan Univ Med Sci, Dept Thorac Surg, Poznan, Poland
[3] Poznan Univ Med Sci, Dept Clin Pathol, Poznan, Poland
[4] Greater Poland Canc Ctr, Dept Epidemiol & Canc Prevent, Poznan, Poland
来源：
POLISH JOURNAL OF PATHOLOGY | 2017年 / 68卷 / 04期
关键词：
neuroendocrine markers; neuroendocrine tumours; pulmonary pathology; HEALTH-ORGANIZATION CLASSIFICATION; INTERMEDIATE-FILAMENT NESTIN; STEM-CELLS; EXPRESSION; CANCER; CARCINOMA; EPIDEMIOLOGY; GRADE;
D O I：
10.5114/PJP.2017.73924
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
Nestin is considered to be a cancer stem cell marker. Nestin expression in neuroendocrine tumours might be useful to predict prognosis and facilitate treatment planning. 88 patients with neuroendocrine lung tumours operated in the Department of Thoracic Surgery from 2007 to 2015 were included into the study. Immunohistochemical staining for nestin was performed. Clinicopathological and survival data were retrospectively analyzed. Nestin expression was detected in 15 (17%) specimens. Multivariate analysis showed that lymph node metastases (p = 0.0001; hazard ratio (HR) = 3.93; confidence interval (CI) 95%: 1.96-7.87), nestin expression (p = 0.034; HR = 2.30; CI 95%: 1.06-4.99) and patient's age (p = 0.024; HR = 1.04; CI 95%: 1.00-1.09) were independent negative prognostic factors. Nestin expression was significantly higher in large cell neuroendocrine carcinoma when compared with carcinoids (p = 0.001). Collected data support the thesis that nestin can be regarded as a biomarker in patients with neuroendocrine lung tumours.
引用
收藏
页码：291 / 296
页数：4
相关论文
共 50 条
  • [21] Clinical management of atypical carcinoid and large-cell neuroendocrine carcinoma: a multicentre study on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours of the Lung Working Group
    Filosso, Pier Luigi
    Rena, Ottavio
    Guerrera, Francesco
    Moreno Casado, Paula
    Sagan, Dariusz
    Raveglia, Federico
    Brunelli, Alessandro
    Welter, Stefan
    Gust, Lucile
    Pompili, Cecilia
    Casadio, Caterina
    Bora, Giulia
    Alvarez, Antonio
    Zaluska, Wojciech
    Baisi, Alessandro
    Roesel, Christian
    Thomas, Pascal Alexandre
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2015, 48 (01) : 55 - 64
  • [22] Exploring the molecular and biological background of lung neuroendocrine tumours
    Simbolo, Michele
    Di Noia, Vincenzo
    D'Argento, Ettore
    Milella, Michele
    Scarpa, Aldo
    Tortora, Giampaolo
    Bria, Emilio
    Pilotto, Sara
    JOURNAL OF THORACIC DISEASE, 2019, 11 : S1194 - S1198
  • [23] Prognostic impact of nestin expression in resected large cell neuroendocrine carcinoma of the lung
    Ryuge, Shinichiro
    Sato, Yuichi
    Jiang, Shi Xu
    Wang, Guoqin
    Matsumoto, Toshihide
    Katono, Ken
    Inoue, Hayato
    Iyoda, Akira
    Satoh, Yukitoshi
    Yoshimura, Hirokuni
    Masuda, Noriyuki
    LUNG CANCER, 2012, 77 (02) : 415 - 420
  • [24] Vasculogenic mimicry and its clinical significance in medulloblastoma
    Wang, Shi-yong
    Yu, Li
    Ling, Geng-qiang
    Xiao, Sha
    Sun, Xin-lin
    Song, Zhen-hua
    Liu, Yi-jing
    Jiang, Xiao-dan
    Cai, Ying-qian
    Ke, Yi-quan
    CANCER BIOLOGY & THERAPY, 2012, 13 (05) : 341 - 348
  • [25] Expression of nestin in ovarian serous cancer and its clinicopathologic significance
    He, Q. -Z.
    Luo, X. -Z.
    Zhou, Q.
    Wang, K.
    Li, S. -X.
    Li, Y.
    Zhu, H. -T.
    Duan, T.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2013, 17 (21) : 2896 - 2901
  • [26] Association of SOX2 and Nestin DNA amplification and protein expression with clinical features and overall survival in non-small cell lung cancer: A systematic review and meta-analysis
    Li, Qingbao
    Liu, Fang
    Zhang, Yuan
    Fu, Lei
    Wang, Cong
    Chen, Xuan
    Guan, Shanghui
    Meng, Xiangjiao
    ONCOTARGET, 2016, 7 (23) : 34520 - 34531
  • [27] Nomogram for individually predicting overall survival in rectal neuroendocrine tumours
    Xingyu Feng
    Gengzhou Wei
    Wei Wang
    Yu Zhang
    Yujie Zeng
    Minhu Chen
    Ye Chen
    Jie Chen
    Zhiwei Zhou
    Yong Li
    BMC Cancer, 20
  • [28] Sequence of therapy and survival in patients with advanced pancreatic neuroendocrine tumours
    Tsang, E. S.
    Loree, J. M.
    Speers, C.
    Kennecke, H. F.
    CURRENT ONCOLOGY, 2020, 27 (04) : 215 - 219
  • [29] Prognostic significance of laterality in lung neuroendocrine tumors
    La Salvia, Anna
    Persano, Irene
    Siciliani, Alessandra
    Verrico, Monica
    Bassi, Massimiliano
    Modica, Roberta
    Audisio, Alessandro
    Zanata, Isabella
    Marinucci, Beatrice Trabalza
    Trevisi, Elena
    Puliani, Giulia
    Rinzivillo, Maria
    Parlagreco, Elena
    Baldelli, Roberto
    Feola, Tiziana
    Sesti, Franz
    Razzore, Paola
    Mazzilli, Rossella
    Mancini, Massimiliano
    Panzuto, Francesco
    Volante, Marco
    Giannetta, Elisa
    Romero, Carmen
    Appetecchia, Marialuisa
    Isidori, Andrea
    Venuta, Federico
    Ambrosio, Maria Rosaria
    Zatelli, Maria Chiara
    Ibrahim, Mohsen
    Colao, Annamaria
    Brizzi, Maria Pia
    Garcia-Carbonero, Rocio
    Faggiano, Antongiulio
    ENDOCRINE, 2022, 76 (03) : 733 - 746
  • [30] Genotyping of stathmin and its association with clinical factors and survival in patients with ovarian cancer
    Ying, Lisha
    Su, Dan
    Zhu, Jianqing
    Ma, Shenglin
    Katsaros, Dionyssios
    Yu, Herbert
    ONCOLOGY LETTERS, 2013, 5 (04) : 1315 - 1320
12345